dr. litton on the embraca trial in advanced brca1/2 breast cancer
Published 4 years ago • 109 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
9:21
dr. litton on activity of talazoparib in advanced brca1/2 breast cancer
-
1:27
dr. litton on the impact of parp inhibitors in breast cancer
-
2:02
dr. litton on a study of neoadjuvant talazoparib for patients with brca-mutated tnbc
-
1:16
dr. litton on genetic testing in breast cancer
-
4:56
neoadjuvant talazoparib active in brca-mutated early breast cancer | jennifer litton
-
6:35
treatment options for patients with brca1/2
-
0:42
dr. litton on the beth trial
-
1:58
dr. joanne blum on the embraca trial in metastatic brca-mutant breast cancer
-
6:04
germline brca mutations in tnbc
-
4:51
telazoparib vs physicians choice for patients with mbrca1 breast cancer
-
2:21
a study of talazoparib in somatic brca1/2 mutant mbc identified by cfdna or tumor tissue genotyping
-
1:54
dr. dieras on combo of veliparib and chemotherapy in brca1/2-mutant breast cancer
-
1:43
dr. lori pierce on the impact of brca1/2 mutations on breast cancer treatment decisions
-
28:57
2021 force | hereditary cancer | cancer risks, screening & prevention for brca1 or brca2 mutations
-
2:47
embraca: results of talazoparib vs chemotherapy relative to prior ct in patients with advanced b...
-
1:12
neelima denduluri, md, regarding the embraca trial in her2- metastatic breast cancer
-
1:21
dr. louis weiner discusses the t-dm1 emilia trial for her2-positive breast cancer
-
4:10
the embraca trial for advanced breast cancer, a new parp inhibitor
-
1:18
dr. robson on exploratory analysis from olympiad in breast cancer